Document:

EX-10.32(a)

 Exhibit 10.32(a) 

 

					
	

	 	 Bioventus LLC

4721 Emperor Blvd., Suite 100
 Durham, NC 27703

USA
	  	1-919-474-6700
 1-800-396-4325

www.BioventusGlobal.com

 October 17, 2019 
 Anthony
P. Bihl III 
 Dear Tony: 
 Based on a review
of federal tax law, it has recently been determined that due to your receipt of certain Profits Interest Unit grants from Bioventus LLC (the “Company”), your employment status with the Company is as a partner of the Company and not as an
employee of the Company. As such, the purpose of this letter is to (a) notify you that your relationship with the Company has been officially reclassified from “employee” status to “partner” status effective October 20,
2019 and (b) provide you with a summary of how this change in classification affects your compensation and benefits, as well as the tax and tax withholding implications of this change. The following is a summary of the impact of your change in
status on these items: 
  

	 	1.	 Your compensation, including base pay and bonus target (AIP), remains unchanged; however, you will no longer
receive such compensation as a W-2 employee, but instead will receive a “guaranteed payment” as a partner in the Company partnership. Your guaranteed payments will continue to be made to you on the
date that the Company makes its regular payroll payments to its employees (bi-weekly). In addition to the guaranteed payments, you will also receive a “benefits stipend” and “tax stipend”,
each of which are described below. Due to your partner status, the Company will no longer withhold any taxes from your guaranteed or other payments made to you. On an annual basis, the Company will provide you with a Schedule K-1 for federal and state income tax purposes. 

  

	 	2.	 Except for the Company’s cafeteria plan for which partners are not eligible to participate, all other
employee benefits with the Company will remain unchanged with respect to your ability to participate in such benefit programs and arrangements, e.g., health and welfare plan benefits, life insurance, retirement (401(k) and 401(k) plus);
provided, however, that all benefits (except for 401(k) and 401(k) plus) for which the Company previously paid certain amounts on your behalf which were exempt from income taxation will now be taxable income to you. As such, the Company will provide
you with an annual “benefits stipend” (which will be taxable income to you) that is equal to the aggregate value of the amount the Company would have paid on your behalf (and which would have been
tax-preferred if you were an employee of the Company and not a partner), which you may, but are not required to, use to defray the cost of non-retirement related health
and welfare benefit coverages you elect to secure for yourself and your eligible dependents (whether as a participant in Company sponsored plans or otherwise). The benefits stipend will be paid bi-weekly on
the same date that the Company pays the guaranteed payments to you. The benefits stipend will be “grossed up” to offset any tax implications and the formula for calculation is noted in Addendum A. 

 

	 	3.	 Should you elect to participate in the Company’s health and welfare plans, you must notify the
Company’s Benefits Manager during the Company’s annual open enrollment period, indicating which plans you wish to enroll. If you chose not to participate in any of the Company’s plans, you will continue to receive that portion of the
benefits stipend that is equal to the aggregate value of the amount the Company would have paid on your behalf for such benefit, which sum may, but is not required to, be used to purchase such benefit from a provider of your choice.

	 	4.	 Please also note that (a) your current Change in Control agreement and Severance Benefits agreement with
the Company remain unchanged and (b) your participation in the 401(k) plan and 401(k) plus plan remain unchanged, with the only exception that you will now be deferring “earned income” as a partner instead of “W-2 compensation” as an employee. You will continue to manage your elections via the provider’s web-site and the Company will continue to make its
contributions according the Plan Document via the third party provider. 

  

	 	5.	 You will receive an annual “tax stipend”, which sum shall be calculated by the Company based on the
difference of a partner versus employee status and will include the portion of FICA taxes equal to a company payment on behalf of an employee, retirement plan tax costs, health and welfare and ancillary benefits tax costs, less tax deductions and/or
credits for health and welfare and ancillary benefits. The actual calculation for this payment is outlined in Addendum A and will be made by the Company each calendar year by March 15th of the
calendar year following the calendar year for which the payment is attributable. 

  

	 	6.	 In addition, you will be eligible to receive tax and other distributions and allocations as provided for in
Section 3(c) of your Management Incentive Plan Award Agreement, subject to the terms of the Management Incentive Plan and Article 4 of the Bioventus LLC Amended and Restated Limited Liability Company Agreement dated as of May 4, 2012.

  

	 	7.	 All other terms and conditions of your employment relationship with the Company will remain unchanged. You will
continue to be responsible for all of your current duties and responsibilities as Chief Executive Officer of the Company and will be required to adhere and abide by all of the Company’s policies and procedures. You will, however, be required to
sign a new copy of your job description, which will reflect your status as a partner of the Company. 

 We truly
appreciate your patience as we have worked through these changes and we regret the personal inconvenience that this has caused. Please let me know if you have any questions regarding any of the above. If not, please sign where indicated below and
return a copy to me. 
  

	
	 Sincerely,

	
	 /s/ William A. Hawkins
III                            

	 William A. Hawkins III

	 Chairman, Bioventus Board of Managers

 Accepted & Agreed: 
  

	
	/s/ Anthony P. Bihl
III                                    
	 Anthony P. Bihl 10/18/2019

 Date 

  
 2 

 Addendum A 

Benefits Stipend Calculation: 
 Aggregate Value of benefits
stipend on a bi-weekly basis = Employer Contribution for all eligible benefits elected/covered under 
 Biweekly
Aggregate Value of benefits = Biweekly Net Payment 
 Tax Stipend Calculation: 

Bioventus Payroll will calculate the following: 

Employer Medicare portion + Taxes on 401K contributions (company and individual contributions) + cost of H & W and ancillary benefits
plan x a mutually agreed tax rate of 42% less tax deductions and/or credits for health and welfare and ancillary benefits = Tax Stipend 
 Tax rate of 42*%
includes: 
  

	 	•	 	 Federal Tax 

  

	 	•	 	 State Withholding Rate 

 

	 	•	 	 Employer Medicare portion 

*Tax rate will be reviewed annually and adjusted if Federal or State tax rates change. The Tax Stipend will be made by the Company each calendar year by March
15th of the calendar year following the calendar year for which the payment is attributable.EX-10.33

 Exhibit 10.33 

 

					
	 

	 	 Bioventus LLC

4721 Emperor Blvd., Suite 100
 Durham, NC 27703

USA
	  	 1-919-474-6700

1-800-396-4325

www.BioventusGlobal.com

 December 11, 2015 

Mr. William A. Hawkins 
 Dear Bill: 

On behalf of the Board of Managers of Bioventus, I am pleased to offer you the role of member and Chairman of our Board of Managers, effective
January 1, 2016. I personally look forward to working closely with you to continue building a world leading company in orthobiologics. This letter outlines the terms and conditions of your appointment to serve as a member and chairman of the
board of managers (the “Board”) of Bioventus LLC (the “Company”). 
 As a member and the chairman of the
Board, you will be expected to attend Board meetings and will have such other duties and responsibilities as are customarily associated with these positions and described in the Amended and Restated Limited Liability Company Agreement of Bioventus
LLC, as it may be further amended from time to time (the “LLC Agreement”). You shall continue to serve on the Board and as chairman until such time as either you or the Company terminates your service in accordance with the terms
and conditions of the LLC Agreement or until such date that Bioventus Inc. consummates an initial public offering. 
 In consideration of
your services as a member of the Board, the Company will (a) pay you an annual retainer fee of $40,000 for your service as a member of the Board and $50,000 for your service as chairman of the Board, both payable in quarterly installments in
arrears and pro-rated for any partial period of service and (b) grant you 50,000 phantom profits interest units under the Company’s phantom profits interests plan (the terms and conditions of which
shall be set forth in a separate award agreement). In addition, the Company will reimburse you in accordance with the applicable Company policy for reasonable travel and other
out-of-pocket expenses incurred in connection with your service on the Board. 

As a member of the Board, you will be entitled to coverage under a directors’ and officers’ liability insurance policy maintained by
the Company and you will be subject to and comply with all Board policies as may be adopted from time to time, including without limitation, any Code of Conduct or Confidentiality Policy. 

During your tenure as a member of the Board, you shall at all times and for all purposes be acting as an independent contractor and not as an
employee of the Company. Accordingly, you will not be eligible to participate in employee benefit plans provided by the Company to its employees and the Company will not, on your account, (i) pay any unemployment tax or other taxes required
under the law to be paid with respect to employees or (ii) withhold any monies from any compensation paid to you for income or employment tax purposes. Board-member compensation is established by the Board and so, notwithstanding this letter,
it may be revised at any time and from time to time. 

 Upon the completion of the initial public offering of Bioventus Inc. common stock, you will
become a director of Bioventus Inc. (and will receive compensation in such capacity) and at such time as you become a director of Bioventus Inc. you will cease to receive separate compensation for your services as a member of the Company’s
Board. 
 Please confirm that the foregoing reflects your understanding by signing and returning to us the enclosed duplicate of this letter
at your earliest convenience. 
 Again Bill, I am very excited about our future with you as a member and Chairman of our Board. Please feel
free to contact me should you wish to discuss any aspect this opportunity or of your service on the Company’s Board. 
  

	
	Sincerely,
	
	 /s/ Anthony P. Bihl III

	Anthony P. Bihl III
	Chief Executive Officer

  

	
	Accepted & Agreed:
	
	 /s/ William A. Hawkins

	William A. Hawkins
	  
 12/21/15

	Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]